Newswise — UCLA researchers have identified four biomarkers that could help doctors diagnose brain trauma and concussions through a simple blood test. The biomarkers are proteins, from brain cells called astrocytes, which are released instantly into the bloodstream when astrocytes’ outer membranes rupture from blunt impact or whiplash trauma.
Mild traumatic brain injuries, also called concussions, often go undiagnosed, but they can lead to lasting neurological impairment, especially after repeated occurrences.
Currently, doctors use CT scans or a standard scoring system to describe the level of consciousness in a person who has suffered a blow to the head. But research has shown that neither approach correlates well with recovery or disability, and both approaches may not help identify milder brain injuries, like concussions. As a result, people with the types of mild head injuries that are often seen among athletes and military personnel frequently don’t take the proper steps for recovery.
Because of the shortcomings of the current diagnostic methods, scientists have been searching for a brain injury “signature” that could objectively identify milder traumatic brain injury early on, as well as assess the severity of TBIs to guide treatment.
In the lab, Ina Wanner, an associate neuroscientist at the David Geffen School of Medicine at UCLA, mechanically “injured” human astrocytes using abrupt pressure pulses. She found that the astrocytes leaked substantial amounts of certain proteins. When the researchers analyzed cerebral spinal fluid from patients who had suffered a TBI, they found the same set of astrocyte proteins.
Wanner wanted to find out if these trauma-released proteins from astrocytes could also be found in the bloodstream. A blow to the head sends shock waves through brain tissue, tearing apart cells, rupturing cell membranes. Because astrocytes have numerous extensions that attach to capillaries and blood vessels, any rupture in this connection allows proteins to directly enter the circulation — even after minor injuries.
Beginning on the day of injury and for up to five days after, the scientists analyzed blood samples from people who had suffered traumatic brain injuries of varying degrees of severity. They discovered that three of the new biomarkers appeared in patients’ blood as soon as one hour after an injury, and even when the injuries were mild enough that they couldn’t be detected by CAT scan. The study showed that those three proteins are released from wounded, compromised cells. The fourth biomarker was exclusively associated with cell death after trauma.
A new biomarker panel based on the research would make it possible for the first time to diagnose mild traumatic brain injury and to monitor brain tissue compromise as it occurs. The advance could be especially important because diagnosing a concussion within an hour after the injury could make a critical difference in preventing repeated hits, promoting rest and recovery and averting chronic symptoms.
In addition to Wanner, the study’s authors are Albert Chong, Gregg Czerwieniec, Thomas Glenn, Julia Halford, David Hovda, Kyohei Itamura, Jaclynn Levine, Joseph Loo, Sean Shen and Paul Vespa, all of UCLA; Ross Bullock of Jackson Memorial Hospital in Miami; Dalton Dietrich of the University of Miami-Miller School of Medicine; and Stefania Mondello of the University of Messina, Italy.
The study was published in the Journal of Cerebral Blood Flow and Metabolism.
The work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, the Miami Project to Cure Paralysis/the Buoniconti Fund, the UCLA Brain Injury Research Center and Abbott Diagnostics.